Announcements
June 28, 2018

LOINC honors Pamela D. Banning for contributions to advancement of health data interoperability

Left to right: Clem McDonald, Pamela Banning and Dan Vreeman

INDIANAPOLIS, IN — LOINC, the world’s most widely used code system for identifying medical tests, observations, and documents, has announced the recipient of the annual LOINC Award for Distinguished Contributions. The award honors individuals whose work advances the interoperability of medical data so that it can be electronically exchanged, understood, and used to improve health.

Pamela D. Banning, MLS(ASCP)cm, PMP®(PMI) of West Linn, OR, was presented with the award at the LOINC meeting in June. Banning has served as a member of the Laboratory LOINC Committee since its early days, missing only one meeting in two decades. Throughout her career, Banning has been a passionate champion of LOINC for data interoperability. In over 20 years, Banning has mapped hundreds of thousands of local lab codes to LOINC for 3M’s clients (and previously for ARUP), including the U.S. Department of Defense. She helped incorporate the terminology into the 3M Healthcare Data Dictionary. She has also supported international implementations of LOINC with Canada Health Infoway and Singapore’s Ministry of Health. Banning is a strong LOINC advocate, guiding educational efforts and encouraging community involvement. Banning’s friendly smile and warm personality are as notable as her many LOINC accomplishments.

Left to right: Clem McDonald, Pamela Banning and Dan Vreeman Pamela D. Banning, 2018 winner of the LOINC Award for Distinguished Contributions with Clement McDonald (l) and Daniel Vreeman (r)
Photo Credit: Timothy Yates, Photographer/IU School of Medicine

Pamela D. Banning, 2018 winner of the LOINC Award for Distinguished Contributions with Clement McDonald (l) and Daniel Vreeman (r)Photo Credit: Timothy Yates, Photographer/IU School of Medicine

LOINC is used as a standard coding system in 172 countries, and is available with many language translations. The Regenstrief Institute is the owner, developer, and overall steward for LOINC. It’s users include a wide spectrum across the health ecosystem, such as healthcare institutions, clinical laboratories and diagnostic testing centers, health information exchanges, health IT vendors and app developers, health insurers, ministries and departments of health, and other government entities around the world. U.S. government agencies in the LOINC community include the National Library of Medicine, the departments of Veterans Affairs and Defense, the Indian Health Service, the National Cancer Institute, the Centers for Disease Control and Prevention, and the Food and Drug Administration.

“Many people know LOINC as the most widely used international standard of names and codes for medical results, observations, and documents in the world,” said Regenstrief Institute investigator Daniel Vreeman, PT, DPT, MS. “But LOINC is also a vibrant, open, and collaborative community. Thanks to dedicated people like Pam Banning, we are constantly expanding both the clinical content in LOINC and users of the standard, with the ultimate goal of improving human health.” Vreeman serves as Director, LOINC and Health Data Standards in the Center for Biomedical Informatics at the Regenstrief Institute.

With support from the U.S. National Library of Medicine, the Regenstrief Institute and other organizations, LOINC is an open, freely available standard. Updates to LOINC are issued twice annually.

Media Contact

Cindy Fox Aisen
Regenstrief Institute
317-843-2275
caisen@Iupui.edu

Related News

Researchers to study online therapy’s potential to prevent cognitive decline in ICU survivors

Researchers to study online therapy’s potential to prevent cognitive decline in ICU survivors

Indianapolis – Researchers from Indiana University Indianapolis, Regenstrief Institute and the IU School of Medicine’s Indiana Alzheimer’s Disease Research

Malaz Boustani, M.D., MPH, Paul Dexter, M.D., Zina Ben Miled, PhD, M.S.

Dementia risk prediction: Zero-minute assessment at less than a dollar cost

Risk detection is important for care management and may alter course of the disease INDIANAPOLIS – A new study

Joshua Vest, PhD, MPH

Regenstrief Institute researcher appointed associate dean for research at IU Indianapolis Fairbanks School of Public Health

Regenstrief Institute Research Scientist Joshua Vest, PhD, MPH, has been appointed associate dean for research at the Indiana University

Alzheimer Disease as a Clinical-Biological Construct-An International Working Group Recommendation

Title: Alzheimer Disease as a Clinical-Biological Construct-An International Working Group Recommendation Published in the journal JAMA Neurology. Here is